A pharmacogenetic versus a clinical algorithm for warfarin dosing SE Kimmel, B French, SE Kasner, JA Johnson, JL Anderson, BF Gage, ... New England Journal of Medicine 369 (24), 2283-2293, 2013 | 852 | 2013 |
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study MA Perera, LH Cavallari, NA Limdi, ER Gamazon, A Konkashbaev, ... The Lancet 382 (9894), 790-796, 2013 | 305 | 2013 |
Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial LC Chappell, P Brocklehurst, ME Green, R Hunter, P Hardy, E Juszczak, ... The Lancet 394 (10204), 1181-1190, 2019 | 166 | 2019 |
Biometric authentication using fast correlation of near infrared hand vein patterns M Shahin, A Badawi, M Kamel International Journal of Biological and Medical Sciences 2 (3), 141-148, 2007 | 155 | 2007 |
Genetic and nongenetic factors associated with warfarin doserequirements in Egyptian patients MHA Shahin, SI Khalifa, Y Gong, LN Hammad, MTH Sallam, M El Shafey, ... Pharmacogenetics and genomics 21 (3), 130-135, 2011 | 128 | 2011 |
Laparoscopic hernia repair versus open herniotomy in children: a controlled randomized study R Shalaby, R Ibrahem, M Shahin, A Yehya, M Abdalrazek, I Alsayaad, ... Minimally Invasive Surgery 2012, 2012 | 117 | 2012 |
Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta‐Analysis E Danese, M Montagnana, JA Johnson, AE Rettie, CF Zambon, SA Lubitz, ... Clinical Pharmacology & Therapeutics 92 (6), 746-756, 2012 | 87 | 2012 |
Pharmacometabolomic assessments of atenolol and hydrochlorothiazide treatment reveal novel drug response phenotypes DM Rotroff, MH Shahin, SB Gurley, H Zhu, A Motsinger‐Reif, M Meisner, ... CPT: pharmacometrics & systems pharmacology 4 (11), 669-679, 2015 | 40 | 2015 |
Genetic and nongenetic factors affecting clopidogrel response in the Egyptian population BM Khalil, MH Shahin, MHM Solayman, T Langaee, MF Schaalan, ... Clinical and translational science 9 (1), 23-28, 2016 | 39 | 2016 |
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals E Danese, S Raimondi, M Montagnana, A Tagetti, T Langaee, P Borgiani, ... Clinical Pharmacology & Therapeutics 105 (6), 1477-1491, 2019 | 36 | 2019 |
Association of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patients L Weng, E Quinlivan, Y Gong, AL Beitelshees, MH Shahin, ST Turner, ... Metabolic syndrome and related disorders 13 (5), 195-202, 2015 | 34 | 2015 |
Detection of Helicobacter pylori vacA, cagA and iceA1 virulence genes associated with gastric diseases in Egyptian patients A El-Shenawy, M Diab, M Shemis, M El-Ghannam, D Salem, ... Egyptian Journal of Medical Human Genetics 18 (4), 365–371-365–371, 2017 | 33 | 2017 |
VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians MHA Shahin, LH Cavallari, MA Perera, SI Khalifa, A Misher, T Langaee, ... Thrombosis and haemostasis 109 (06), 1045-1050, 2013 | 33 | 2013 |
A genetic response score for hydrochlorothiazide use: insights from genomics and metabolomics integration MH Shahin, Y Gong, CW McDonough, DM Rotroff, AL Beitelshees, ... Hypertension 68 (3), 621-629, 2016 | 30 | 2016 |
Mechanisms and pharmacogenetic signals underlying thiazide diuretics blood pressure response MH Shahin, JA Johnson Current opinion in pharmacology 27, 31-37, 2016 | 30 | 2016 |
Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice? MHA Shahin, JA Johnson Current opinion in cardiology 28 (3), 305-314, 2013 | 28 | 2013 |
Beta2 receptor agonists and antagonists NER Abosamak, MH Shahin StatPearls [Internet], 2023 | 27 | 2023 |
Open data revolution in clinical research: opportunities and challenges MH Shahin, S Bhattacharya, D Silva, S Kim, J Burton, J Podichetty, ... Clinical and Translational Science 13 (4), 665-674, 2020 | 25 | 2020 |
Is a Diabetes Mellitus–Linked Amino Acid Signature Associated With β-Blocker–Induced Impaired Fasting Glucose? RM Cooper-DeHoff, W Hou, L Weng, RA Baillie, AL Beitelshees, Y Gong, ... Circulation: Cardiovascular Genetics 7 (2), 199-205, 2014 | 25 | 2014 |
Spectrophotometric determination of lesinurad and allopurinol in recently approved FDA pharmaceutical preparation AA Mohamed, A El-Olemy, S Ramzy, AH Abdelazim, MKM Omar, ... Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 247, 119106, 2021 | 21 | 2021 |